0001104659-21-069940.txt : 20210520
0001104659-21-069940.hdr.sgml : 20210520
20210520163651
ACCESSION NUMBER: 0001104659-21-069940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210518
FILED AS OF DATE: 20210520
DATE AS OF CHANGE: 20210520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOB GARY S
CENTRAL INDEX KEY: 0001266802
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36856
FILM NUMBER: 21944992
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hepion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001583771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462783806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
BUSINESS PHONE: 732-902-4000
MAIL ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
FORMER COMPANY:
FORMER CONFORMED NAME: ContraVir Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130806
4
1
tm2117144d6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-05-18
0
0001583771
Hepion Pharmaceuticals, Inc.
HEPA
0001266802
JACOB GARY S
C/O HEPION PHARMACEUTICALS, INC.
399 THORNALL STREET, FIRST FLOOR
EDISON
NJ
08837
1
0
0
0
Stock Options
1.70
2021-05-18
4
A
0
250000
0
A
2022-05-18
2031-05-18
Common Stock
250000
342785
D
Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.
/s/ Gary Jacob
2021-05-20